Who owns BioCryst Pharmaceuticals, Inc.?
Institutional ownership of BCRX from SEC Form 13F filings across 220 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
220
13F holders
$1.57B
value, 2026 filers
62.7%
of shares outstanding (159.3M sh)
37
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of BCRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 23.9M | $238.9M | 0.0% | 9.4% | +5.5% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 11.4M | $113.6M | 0.0% | 4.5% | -49.0% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 11.1M | $111.4M | 0.0% | 4.4% | -0.9% |
| 4 | TCG Crossover Management, LLC | 11.0M | $110.2M | 2.6% | 4.3% | 0.0% |
| 5 | Jupiter Topco LLCNEW | 9.5M | $95.3M | 0.0% | 3.8% | new |
| 6 | TWO SIGMA INVESTMENTS, LP | 6.8M | $67.8M | 0.0% | 2.7% | +6.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 6.2M | $62.5M | 0.0% | 2.5% | +8.0% |
| 8 | Aberdeen Group plc | 5.3M | $53.1M | 0.1% | 2.1% | +5.4% |
| 9 | UBS Group AG | 5.1M | $50.8M | 0.0% | 2% | +2.7% |
| 10 | BANK OF AMERICA CORP /DE/ | 4.8M | $48.0M | 0.0% | 1.9% | -5.7% |
| 11 | GOLDMAN SACHS GROUP INC | 4.5M | $44.8M | 0.0% | 1.8% | +90.9% |
| 12 | Nuveen, LLC | 4.0M | $40.1M | 0.0% | 1.6% | +4.9% |
| 13 | MILLENNIUM MANAGEMENT LLC | 3.4M | $33.9M | 0.0% | 1.3% | +1708.4% |
| 14 | JANE STREET GROUP, LLC | 2.8M | $27.6M | 0.0% | 1.1% | +343.7% |
| 15 | Fisher Asset Management, LLC | 2.6M | $26.0M | 0.0% | 1% | -4.7% |
| 16 | Candriam S.C.A. | 2.5M | $25.1M | 0.1% | 1% | +10.0% |
| 17 | Sixth Street Partners Management Company, L.P.NEW | 2.4M | $23.5M | 4.1% | 0.9% | new |
| 18 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.4M | $23.5M | 0.0% | 0.9% | +0.1% |
| 19 | NORTHERN TRUST CORP | 2.3M | $22.6M | 0.0% | 0.9% | +7.2% |
| 20 | MORGAN STANLEY | 2.0M | $20.0M | 0.0% | 0.8% | -1.2% |
| 21 | HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.8M | $18.4M | 0.0% | 0.7% | +50.4% |
| 22 | STIFEL FINANCIAL CORP | 1.8M | $18.3M | 0.0% | 0.7% | +0.1% |
| 23 | VANGUARD FIDUCIARY TRUST CO | 1.8M | $17.6M | 0.0% | 0.7% | +5.7% |
| 24 | CITADEL ADVISORS LLC | 1.8M | $17.6M | 0.0% | 0.7% | +72.7% |
| 25 | Legal & General Group Plc | 1.5M | $14.6M | 0.0% | 0.6% | +3.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.